Holen Sie sich die Stockscreener-App
12.95
1.09%
0.14
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$12.81
Offen:
$12.85
24-Stunden-Volumen:
6.65M
Relative Volume:
1.67
Marktkapitalisierung:
$2.58B
Einnahmen:
$3.90B
Nettoeinkommen (Verlust:
$-413.00M
KGV:
-6.256
EPS:
-2.07
Netto-Cashflow:
$365.00M
1W Leistung:
-5.89%
1M Leistung:
+6.76%
6M Leistung:
-6.50%
1J Leistung:
-31.01%
1-Tages-Spanne:
$12.75
$13.13
1-Wochen-Bereich:
$12.70
$14.18
52-Wochen-Spanne:
$9.85
$19.27
Dentsply Sirona Inc Stock (XRAY) Company Profile
Firmenname
Dentsply Sirona Inc
Sektor
Telefon
844-546-3722
Adresse
13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE, NC
Compare XRAY vs ISRG, BDX, ALC, MDLN, RMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XRAY
Dentsply Sirona Inc
|
12.95 | 2.56B | 3.90B | -413.00M | 365.00M | -2.07 |
|
ISRG
Intuitive Surgical Inc
|
485.84 | 169.97B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
175.89 | 50.58B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
79.20 | 38.58B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
MDLN
Medline Inc
|
44.55 | 37.11B | 27.43B | 1.27B | 1.01B | 1.5829 |
|
RMD
Resmed Inc
|
252.55 | 35.80B | 5.40B | 1.49B | 1.78B | 10.12 |
Dentsply Sirona Inc Stock (XRAY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-09 | Eingeleitet | Barclays | Underweight |
| 2025-11-07 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2025-04-15 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-13 | Herabstufung | Needham | Buy → Hold |
| 2025-02-14 | Eingeleitet | Wells Fargo | Equal Weight |
| 2025-01-23 | Herabstufung | Jefferies | Buy → Hold |
| 2025-01-07 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2024-12-04 | Eingeleitet | Mizuho | Neutral |
| 2024-11-07 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-10-25 | Bestätigt | Needham | Buy |
| 2024-08-20 | Bestätigt | Needham | Buy |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2023-11-16 | Eingeleitet | Needham | Buy |
| 2023-11-10 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2023-01-12 | Hochstufung | William Blair | Underperform → Mkt Perform |
| 2022-08-05 | Herabstufung | William Blair | Mkt Perform → Underperform |
| 2022-06-02 | Hochstufung | UBS | Neutral → Buy |
| 2022-04-20 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-04-20 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2022-04-19 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-04-19 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2022-01-31 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-10-01 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-08-09 | Bestätigt | H.C. Wainwright | Neutral |
| 2021-08-06 | Bestätigt | Barrington Research | Outperform |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-03-02 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2021-03-02 | Bestätigt | H.C. Wainwright | Neutral |
| 2021-01-05 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-12-18 | Herabstufung | Stifel | Buy → Hold |
| 2020-11-17 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2020-11-09 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-10-22 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-08-10 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-06-16 | Eingeleitet | Piper Sandler | Overweight |
| 2020-06-15 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-05-27 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2020-05-11 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2020-04-24 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-04-08 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2020-04-07 | Herabstufung | Goldman | Buy → Neutral |
| 2020-04-02 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2020-03-03 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-02-19 | Bestätigt | Stifel | Buy |
| 2019-12-11 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2019-08-02 | Hochstufung | Wellington Shields | Hold → Gradually Accumulate |
| 2019-07-26 | Eingeleitet | Evercore ISI | In-line |
| 2019-07-09 | Bestätigt | H.C. Wainwright | Neutral |
| 2019-05-30 | Eingeleitet | Wolfe Research | Peer Perform |
Alle ansehen
Dentsply Sirona Inc Aktie (XRAY) Neueste Nachrichten
Dental Plaster Market Outlook 2026-2033: Growth Drivers, - openPR.com
Inside the Dentsply Sirona Ruling: Which Claims Moved Forward—and Why - TipRanks
Dental Impression Systems Market Size, Share | Forecast [2034] - Fortune Business Insights
Global Shift to Clear Aligners to Build a USD 99.44 Billion Market by 2034 - GlobeNewswire Inc.
Dental Crown Market is expected to reach US$ 7.25 Billion by 2033 | - openPR.com
Dental 3D Printing Market Poised for Transformation: Insights - openPR.com
DENTSPLY SIRONA Inc. $XRAY Position Increased by Savant Capital LLC - MarketBeat
Allianz Asset Management GmbH Has $17.20 Million Stock Position in DENTSPLY SIRONA Inc. $XRAY - MarketBeat
Dentsply 61C103 SureFil SDR Flow + Bulk Fill Flowable CompositeUniversal Shade, 0.25 Gm - hotelier.com.py
United States Dental Digital X-ray Market to Grow at 9% CAGR - openPR.com
Dental Equipment Market is expected to reach US$ 12.4 billion - openPR.com
Dental Membrane And Bone Graft Substitutes Market Analysis - openPR.com
Intraoral Scanners Market Outlook 2026-2033: Capacity - openPR.com
Dentsply Sirona to Host Fourth Quarter and Full Year Conference Call on February 26 - marketscreener.com
Dental sector may steady in 2026, but full recovery remains distant, analysts say - Sahm
Digital Orthodontics Market is expected to reach US$ 22.95 - openPR.com
Expert Outlook: Dentsply Sirona Through The Eyes Of 9 Analysts - Benzinga
UBS Adjusts DENTSPLY SIRONA Price Target to $16 From $17, Maintains Buy Rating - marketscreener.com
UBS Maintains Buy Rating on Dentsply Sirona (XRAY) But Lowers Pr - GuruFocus
Indwelling Catheters Market Analysis 2026-2033: Strategic - openPR.com
Is Weak Revenue And ROIC Undermining The Investment Case For DENTSPLY SIRONA (XRAY)? - Sahm
Mitsubishi UFJ Trust & Banking Corp Purchases 100,468 Shares of DENTSPLY SIRONA Inc. $XRAY - MarketBeat
Assessing Dentsply Sirona (XRAY) Valuation After Softer Results And Ongoing Profitability Concerns - Yahoo Finance
Y Intercept Hong Kong Ltd Has $1.30 Million Stock Position in DENTSPLY SIRONA Inc. $XRAY - MarketBeat
A Look At Dentsply Sirona (XRAY) Valuation After Recent Share Price Rebound - Sahm
Dentsply Sirona’s Revenue Struggles And Capital Woes Test Turnaround Story - Yahoo Finance
Dental Burs Market 2025 (NA 35%, APAC 30%, Europe 25%)Driven - openPR.com
Dentsply Sirona (XRAY): Buy, Sell, or Hold Post Q3 Earnings? - Yahoo Finance
Dentsply Sirona Inc (XRAY) Trading Down 3.05% on Jan 28 - GuruFocus
Global Dental Market Forecast Report and Company Analysis - GlobeNewswire
All about Dentsply Sirona World Dubai 2026 - Dental Tribune US
Cooke & Bieler LP Decreases Stake in DENTSPLY SIRONA Inc. $XRAY - MarketBeat
Dental NewsDENTSPLY–Sirona merger to create world's largest dental manufacturer - Dental Tribune US
Options Flow: Is DENTSPLY SIRONA Inc stock good for income investors2025 Pullback Review & Weekly Top Performers Watchlists - baoquankhu1.vn
Investment Review: Is Adicet Bio Inc. attractive for institutional investorsOptions Play & Short-Term High Return Strategies - baoquankhu1.vn
The Truth About Dentsply Sirona Inc: Wall Street Sleeper or Next Big Health-Tech Play? - AD HOC NEWS
Lobbying Update: $20,000 of DENTSPLY SIRONA INC. lobbying was just disclosed - Quiver Quantitative
BofA Securities Maintains Dentsply Sirona(XRAY.US) With Hold Rating, Announces Target Price $13 - 富途资讯
Dental Market Dynamics and Contributions by Dentsply Sirona, - openPR.com
Dentsply Sirona (XRAY) Gains 4.4% After Mizuho Raises Price TargetNews and Statistics - IndexBox
Dentsply Sirona (XRAY) Stock Is Up, What You Need To Know - The Globe and Mail
Dental Market Overview and Leading Players: Dentsply Sirona, - openPR.com
Analysts Have Conflicting Sentiments on These Healthcare Companies: Agilent (A), DENTSPLY SIRONA (XRAY) and Exact Sciences (EXAS) - The Globe and Mail
DENTSPLY SIRONA Inc. $XRAY Shares Sold by Campbell & CO Investment Adviser LLC - MarketBeat
Dentsply Can't Shed Investors' Aligner Injury Cover-Up Suit - Law360
Mizuho Analyst Steven Valiquette Raises Price Target for XRAY to $14.00 | XRAY Stock News - GuruFocus
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Given Consensus Rating of "Reduce" by Analysts - MarketBeat
Dentsply Investors Advance Byte Teeth Aligner Injury Claims (3) - Bloomberg Law News
A Look At Dentsply Sirona (XRAY) Valuation After Renewed Patterson And Expanded Benco Distribution Deals - Sahm
Nordea Investment Management AB Purchases 142,451 Shares of DENTSPLY SIRONA Inc. $XRAY - MarketBeat
DS World Dubai opens with focus on connected dentistry - Dental Tribune US
Finanzdaten der Dentsply Sirona Inc-Aktie (XRAY)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.53%
1.58%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):